1.Observation on the therapeutic effect of painless festering moxibustion on knee osteoarthritis.
Yong FU ; Ming-fei KANG ; Ri-xin CHEN ; Bo ZHANG ; Hai-feng ZHANG
Chinese Acupuncture & Moxibustion 2007;27(7):513-515
OBJECTIVETo observe the therapeutic effect of painless festering moxibustion on knee osteoarthritis and to probe into a new therapy.
METHODSThirty-four cases of knee osteoarthritis were treated with painless festering moxibustion at the best moxibustion part close to the knee joint. The internationally acknowledged knee joint function rating scale (percentage method) including such indexes as pain, walking, joint flexion mobility, instability, engorgement, stair activity and twist-locking before and after treatment was used for assessment of the therapeutic effect.
RESULTSTen cases were cured, 14 cases were markedly effective, 9 cases were effective and 1 cases was ineffective, with a total effective rate of 97.060%.
CONCLUSIONPainless festering moxibustion has an obvious therapeutic effect on knee osteoarthritis.
Adult ; Aged ; Female ; Humans ; Male ; Medicine, Chinese Traditional ; Middle Aged ; Moxibustion ; methods ; Osteoarthritis, Knee ; therapy
3.Moxibustion on heat-sensitive acupoints for treatment of myofascial pain syndrome: a multi-central randomized controlled trial.
Ri-Xin CHEN ; Ming-Fei KANG ; Wei-Li HE ; Shi-Yong CHEN ; Bo ZHANG
Chinese Acupuncture & Moxibustion 2008;28(6):395-398
OBJECTIVETo observe the clinical therapeutic effect of moxibustion on heat-sensitive acupoints on myofascial pain syndrome (MPS).
METHODSThree-centre, single blind, randomized controlled trial method was adopted. One hundred and seven cases were randomly divided into an observation group (n = 57), and a control group (n = 50). The observation group were treated by moxibustion on the heat-sensitive acupoints and the control group by acupuncture, cupping and TDP. The therapeutic effects were assessed according to changes of the score of the short-form of McGill pain questionnaire composing of pain rating index (PRI), visual analogue scale (VAS) and present pain intensity (PPI) before and after treatment.
RESULTSThe cured rate of 86.0% in the observation group was better than 24.0% in the control group. After treatment, the score of PRI, VAS, PPI indexes significantly improved in the observation group (P < 0.001), and were significantly better than those in the control group (P < 0.001).
CONCLUSIONMoxibustion on the heat-sensitive acupoints has a high therapeutic effect on MPS.
Acupuncture Points ; Adult ; Aged ; Female ; Hot Temperature ; Humans ; Male ; Middle Aged ; Moxibustion ; Myofascial Pain Syndromes ; therapy ; Pain Measurement
4.Enzyme-linked immunosorbent assay for detecting anti-pertussis toxin antibody in mouse.
Gi Sub CHOI ; Dong Ho HUH ; Seung Beom HAN ; Dong Ho AHN ; Kyu Ri KANG ; Ji Ahn KIM ; Bo Mi CHOI ; Hea Ryun KIM ; Jin Han KANG
Clinical and Experimental Vaccine Research 2019;8(1):64-69
PURPOSE: Although the DTaP and Tdap vaccines used to prevent pertussis have been used for a long time, there is no standard method for measuring pertussis antigens. Therefore, this preliminary study was conducted to develop an enzyme-linked immunosorbent assay method using an animal model for measuring antibodies against pertussis toxin, the most important pertussis pathogenic antigen, in the sera of vaccinated mice. MATERIALS AND METHODS: Bordetella pertussis Tohama phase I was cultured for 24–30 hours, and then pertussis toxin was purified from the culture medium by chromatography. Purified pertussis toxin was diluted in phosphate-buffered saline-coating buffer, and 100 µL of diluted pertussis toxin was added to each well and reacted at room temperature for 4 hours. Positive serum was diluted to 1/1,250–1/80,000 and negative serum was diluted to 1/50 to determine the coating concentration with the optimal signal/noise ratio. Optimal test conditions were confirmed from the dilution factors of the secondary antibody and streptavidin horseradish peroxidase (SA-HRP). RESULTS: Optimal conditions were as follows: 4 µg/mL for coating antigen; 1/40,000 for secondary antibody; and 1/1,000 for the SA-HRP dilution factor. Comparison of the sera obtained from mice treated with a developing vaccine and commercial vaccine with National Institute for Biological Standard and Control standard serum under the established conditions showed the following results: 1,300.62, 534.94, and 34.85, respectively. CONCLUSION: The method developed in this study is suitable for measuring anti-pertussis toxin antibodies and may be applicable for clinical sample analysis or indirect diagnosis of pertussis.
Animals
;
Antibodies
;
Bordetella pertussis
;
Chromatography
;
Diagnosis
;
Enzyme-Linked Immunosorbent Assay*
;
Horseradish Peroxidase
;
Methods
;
Mice*
;
Models, Animal
;
Pertussis Toxin
;
Streptavidin
;
Vaccines
;
Whooping Cough
5.A clinical consideration about clinical manifestations of the Bromate poisoning.
Hyun Hee NA ; Bo Ri KANG ; Jung A SHIN ; Ji Sun LEE ; Young Jung PARK ; Won Do PARK
Korean Journal of Medicine 2004;67(Suppl 3):S788-S793
Bromate which is an oxidant exists as a form of potassium bromate (KBrO3) and sodium bromate (NaBrO3) and has been primarily used as a permanent neutralizer in a household. In 1985, that has been reported for clinical course of bromate poisoing. After 1985, many variable clinical manifestation of the bromate poisoning were reported in Korea. In 2003, three patients of the bromate poisoing admited in Sanggye Paik hospital,Inje university school of medicine, Korea. In this work, the bromate poisoning was investigated based on 3 cases experienced previously 8 cases reported in Korea and compared with the case report of foreign country.
Acute Kidney Injury
;
Family Characteristics
;
Hearing Loss
;
Humans
;
Korea
;
Poisoning*
;
Potassium
;
Renal Dialysis
;
Sodium
6.Performance of Automated Chemiluminescence Assay for Antiphospholipid Antibody Testing.
Shuhua LI ; Jae Lim CHOI ; Bo Ram KIM ; Cheol Soo KANG ; Ri Young GOH ; Kwang Sook WOO ; Jin Yeong HAN
Journal of Laboratory Medicine and Quality Assurance 2015;37(3):134-140
BACKGROUND: Detection of antiphospholipid antibodies (aPL) can be considered problematic due to assay variability and reagent sensitivity, high false-positive and false-negative rates, and lack of assay standardization. Therefore, utilizing an automated system can improve reproducibility and reduce interlaboratory variation. Here, we evaluated the analytical performance of the new automated ACL AcuStar chemiluminescence assay (Instrumentation Laboratory, USA). This was compared to the results of a panel analyzed with the QUANTA Lite ELISA (INOVA Diagnostics Inc., USA). METHODS: We evaluated the inter-assay precision, linearity, and carry-over between the two methods, ACL and ELISA. A reference range study for each of the anticardiolipin (aCL) and anti-beta2 glycoprotein-I (abeta2GPI) IgG and IgM antibodies were performed using 135 healthy patient samples, which served as controls. We then compared the accuracy among the AcuStar and ELISA systems via four aPL tests. For this comparison, 69 patient samples suspected of an autoimmune disorder were used as the experimental panel. RESULTS: The AcuStar analyzer showed excellent precision, linearity, and carry-over for all four assays. The calculated cutoff values were 20.3 U/mL for aCL IgG, 20.3 U/mL for aCL IgM, 26.3 U/mL for abeta2GPI IgG, and 11.9 U/mL for abeta2GPI IgM. The consensus between AcuStar and ELISA results were generally comparable. Total agreement varied between 82.6% and 95.7%, and kappa values showed moderate to good agreement. CONCLUSIONS: Our study demonstrates that the new AcuStar chemiluminescence assay showed better performance. This automated system leads to improved reproducibility and reduces interlaboratory variability.
Antibodies
;
Antibodies, Anticardiolipin
;
Antibodies, Antiphospholipid*
;
Antiphospholipid Syndrome
;
Automation
;
Consensus
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Immunoglobulin G
;
Immunoglobulin M
;
Luminescence*
;
Reference Values
7.A Phase I Study of Human Cord Blood-Derived Mesenchymal Stem Cell Therapy in Patients with Peripheral Arterial Occlusive Disease.
Shin Seok YANG ; Na Ri KIM ; Kwang Bo PARK ; Young Soo DO ; Kyounghwan ROH ; Kyung Sun KANG ; Dong Ik KIM
International Journal of Stem Cells 2013;6(1):37-44
BACKGROUND AND OBJECTIVES: Half of patients with critical limb ischemia (CLI) are ineligible for revascularization at diagnosis. The aim of this study was to assess the safety and feasibility of intramuscular human umbilical cord blood-derived mesenchymal stem cell (hUCB-MSC) therapy in patients with CLI due to atherosclerosis obliterans (ASO) or thromboangiitis obliterans (TAO). METHODS AND RESULTS: A total of eight patients (all male, median age 52 years, range 31~77) with CLI were enrolled in this phase I trial. All patients were considered ineligible for further revascularization to improve CLI. We injected 1x10(7) hUCB-MSCs per single dose intramuscularly into the affected limb. The primary end points of safety were occurrence of adverse events (procedure-related complication, allergic reaction to hUCB-MSCs, graft-versus-host disease, cardiovascular and cerebrovascular events) and improvement of symptoms/clinical parameters (healing of foot ulcer, ankle-brachial index, and pain-free walking distance). Angiogenesis was measured with conventional angiography and scored by an independent reviewer. There were four adverse events in three patients. One patient, developed whole body urticaria after injection on treatment day, which disappeared after one day of antihistamine treatment. The other adverse events included diarrhea, oral ulceration, and elevation of serum creatinine level; all conditions improved without treatment. Abnormal results of laboratory parameters were not detected in any patients. Three of four ulcerations (75%) healed completely. Angiographic scores increased in three of eight patients. CONCLUSIONS: This phase I study demonstrates that intramuscular hUCB-MSC injection is a safe and well tolerated treatment for patients with end-stage CLI due to ASO and TAO.
Angiography
;
Ankle Brachial Index
;
Arterial Occlusive Diseases
;
Atherosclerosis
;
Creatinine
;
Diarrhea
;
Extremities
;
Fetal Blood
;
Foot Ulcer
;
Graft vs Host Disease
;
Humans
;
Hypersensitivity
;
Ischemia
;
Male
;
Mesenchymal Stromal Cells
;
Oral Ulcer
;
Oxalates
;
Stem Cells
;
Thromboangiitis Obliterans
;
Troleandomycin
;
Ulcer
;
Umbilical Cord
;
Urticaria
;
Walking
8.Benign Intraductal Papilloma without Atypia on Core Needle Biopsy Has a Low Rate of Upgrading to Malignancy after Excision.
Song Hee HAN ; Milim KIM ; Yul Ri CHUNG ; Bo La YUN ; Mijung JANG ; Sun Mi KIM ; Eunyoung KANG ; Eun Kyu KIM ; So Yeon PARK
Journal of Breast Cancer 2018;21(1):80-86
PURPOSE: The management of benign intraductal papilloma (IDP) without atypia diagnosed on core needle biopsy (CNB) remains controversial. This study was performed to evaluate the rate of upgrading to malignancy or high-risk lesions after excision and to identify factors associated with upgrading using a large series of benign IDP cases without atypia. METHODS: We included patients who were diagnosed as having benign IDP without atypia on CNB and underwent surgical or vacuum-assisted excision between 2010 and 2015. We analyzed the clinical, radiologic, and histopathologic features of IDPs that were upgraded to malignancy or high-risk lesions after excision. RESULTS: A total of 511 benign IDPs without atypia diagnosed via CNB were identified, of which 398 cases were treated with excision. After reviewing these cases, four cases of high-risk lesions in adjacent tissue on CNB, two cases which were revealed as papilloma with atypia, and nine cases of malignancy in the same breast were excluded. In the remaining 383 cases, the rate of upgrading to malignancy and high-risk lesions after excision was 0.8% and 4.4%, respectively. The presence of concurrent contralateral breast cancer, the presence of symptoms, and multifocality were factors significantly associated with upgrading to malignancy on subsequent excision. Surgical excision rather than vacuum-assisted excision was significantly associated with upgrading to high-risk lesions or malignancy. CONCLUSION: The rate of upgrading to malignancy for benign IDP without atypia was very low, suggesting that close clinical and radiologic observation may be sufficient for patients with benign IDP without atypia on CNB under proper settings.
Biopsy, Large-Core Needle*
;
Breast
;
Breast Neoplasms
;
Humans
;
Papilloma
;
Papilloma, Intraductal*
9.Management of Coronary Sinus Ostial Atresia during a Staged Operation of a Functional Single Ventricle.
Seung Ri KANG ; Won Kyoun PARK ; Bo Sang KWON ; Jae Kon KO ; Hyun Woo GOO ; Jeong Jun PARK
The Korean Journal of Thoracic and Cardiovascular Surgery 2018;51(2):130-132
Coronary sinus ostial atresia (CSOA) with persistent left superior vena cava (LSVC) in the absence of an unroofed coronary sinus is a benign and rare anomaly that may be taken lightly in most instances. However, if overlooked in patients undergoing univentricular heart repair such as bidirectional Glenn or Fontan-type surgery, fatal surgical outcomes may occur due to coronary venous drainage failure. We report a case of CSOA with a persistent LSVC that was managed through coronary sinus rerouting during a total cavopulmonary connection, and provide a review of the literature regarding this rare anomaly.
Coronary Sinus*
;
Drainage
;
Fontan Procedure
;
Heart
;
Heart Bypass, Right
;
Humans
;
Vena Cava, Superior
10.Depletion of epsilon-COP in the COPI Vesicular Coat Reduces Cleistothecium Production in Aspergillus nidulans.
Eun Hye KANG ; Eun Jung SONG ; Jun Ho KOOK ; Hwan Hee LEE ; Bo Ri JEONG ; Hee Moon PARK
Mycobiology 2015;43(1):31-36
We have previously isolated epsilon-COP, the alpha-COP interactor in COPI of Aspergillus nidulans, by yeast two-hybrid screening. To understand the function of epsilon-COP, the aneA+ gene for epsilon-COP/AneA was deleted by homologous recombination using a gene-specific disruption cassette. Deletion of the epsilon-COP gene showed no detectable changes in vegetative growth or asexual development, but resulted in decrease in the production of the fruiting body, cleistothecium, under conditions favorable for sexual development. Unlike in the budding yeast Saccharomyces cerevisiae, in A. nidulans, over-expression of epsilon-COP did not rescue the thermo-sensitive growth defect of the alpha-COP mutant at 42degrees C. Together, these data show that epsilon-COP is not essential for viability, but it plays a role in fruiting body formation in A. nidulans.
Aspergillus nidulans*
;
Coatomer Protein*
;
Fruit
;
Homologous Recombination
;
Mass Screening
;
Saccharomyces cerevisiae
;
Saccharomycetales
;
Sexual Development
;
Yeasts